Vaccines & Drugs Market By Vaccine (Macroeconomic indicators , Macroeconomic indicators,Post COVID-19 vaccine approval scenario,Strategies to ramp up production at a pandemic level), ByTherapeutic drugs (Macroeconomic indicators, DMPK,Post COVID-19 approval scenario,Strategies to ramp up production at a pandemic level)- Global Industry Analysis, Share, Growth, Regional Outlook And Forecasts, 2021-2027

The global Vaccines & Drugs market gathered revenue around USD 2,271 Million in 2021 and market is set to grow USD 1,502 Million by the end of 2027 and is estimated to expand at a modest CAGR of 16.7% during the prediction period 2021 to 2027.The growth of the COVID vaccines market is attributed majorly to the rising number of people infected with COVID-19 and increasing funding for vaccine development. The growth of the COVID drugs market is primarily attributed to use of repurposed drugs for compassionate use, and the emergence of alternative therapies such as convalescent plasma therapy which were earlier used for treating epidemic diseases such as SARS, MERS, and H1N1. Moreover, collaborations between global organizations and governments of various nations to promote the supply of essential drugs and medical supplies are fueling the market growth.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Vaccines & Drugs market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Vaccines & Drugs market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Vaccines & Drugs market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Report Highlights Details
Market Size US$ 1,502 Million by 2027
Growth Rate CAGR of 16.7% From 2021 to 2027
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2027
Segments Covered Vaccine,Therapeutic drugs
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Pfizer Inc. (US), Johnson & Johnson Services, Inc (US), GlaxoSmithKline plc. (UK), Sanofi (France) Serum Institute of India (India), among others. Gilead Sciences, Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), Janssen Pharmaceuticals, Inc. (Belgium)

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Significant Market Participants Operational in the Vaccines & Drugs Market are:

The leading players in the Vaccines & Drugs Market are Pfizer Inc. (US), Johnson & Johnson Services, Inc (US), GlaxoSmithKline plc. (UK), Sanofi (France) Serum Institute of India (India), among others. Major players in the COVID-19 drugs market include Gilead Sciences, Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), Janssen Pharmaceuticals, Inc. (Belgium) among others. 

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Vaccine

The current pipeline of vaccines by phase by companies

Competitive landscape (top players in vaccines)

  • Viewpoint on COVID-19 pipeline      
  • Impact of COVID-19 on other vaccines in the portfolio/other under development vaccines  

Macroeconomic indicators          

  • Drivers         
  • Restraints   
  • New opportunities 

Post COVID-19 vaccine approval scenario             

  • Challenges in vaccines approval/production/supply
  • Strategies to overcome challenges         
    • Historic examples (SARS, MERS, Ebola, H1N1)    
    • New strategies

Strategies to ramp up production at a pandemic level    

  • Historic examples           
  • New strategies

Covid-19 vaccine market estimation

  • Epidemiology model (assumption basis)               
  • Pricing strategies (compared to current flu vaccines)      
  • Covid-19 vaccine market (optimistic, pessimistic & realistic)         

Therapeutic drugs

The current pipeline of drugs by phase by companies

Competitive landscape (top players in COVID-19 therapeutic drugs)

  • A view point on the COVID-19 pipeline 
  • Impact of COVID-19 on other products in the portfolio/other under development products        

Macroeconomic indicators          

  • Drivers 
  • Restraints           
  • New opportunities         

Post COVID-19 approval scenario             

  • Challenges in production/manufacturing             
  • Strategies to overcome challenges         
    • Historic examples (SARS, MERS, Ebola, H1N1)    
    • New strategies

Strategies to ramp up production at a pandemic level    

  • Historic examples           
  • New strategies

Covid-19 vaccine market estimation

  • Epidemiology model (assumption basis)               
  • Pricing strategies             
  • Repurpose drugs            
  • New molecules
  • Covid-19 therapy market (optimistic, pessimistic & realistic)        

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Highlights of the Report:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Research Methodology

In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Vaccines & Drugs market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the Vaccines & Drugs market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Vaccines & Drugs markets more accurate and reliable.

Secondary Research

It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Industry participants involved in this research study include:

  • CEOs, VPs, market intelligence managers
  • Procuring and national sales managers technical personnel, distributors and resellers
  • Research analysts and key opinion leaders from various domains

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2027);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Vaccines & Drugs Market, By Vaccine

7.1.  Vaccines & Drugs Market, by Vaccine, 2021-2027

7.1.1.     Competitive landscape (top players in vaccines)

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Macroeconomic indicators     

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Post COVID-19 vaccine approval scenario

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Strategies to ramp up production at a pandemic level

7.1.4.1.          Market Revenue and Forecast (2016-2027)

7.1.5.     Covid-19 vaccine market estimation

7.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Vaccines & Drugs Market, Therapeutic drugs

8.1.  Vaccines & Drugs Market, Therapeutic drugs, 2021-2027

8.1.1.     Competitive landscape (top players in COVID-19 therapeutic drugs)

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Macroeconomic indicators

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Post COVID-19 approval scenario

8.1.3.1.          Market Revenue and Forecast (2016-2027)

8.1.4.     Strategies to ramp up production at a pandemic level

8.1.4.1.          Market Revenue and Forecast (2016-2027)

8.1.5.     Covid-19 vaccine market estimation

8.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Vaccines & Drugs Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.     Market Revenue and Forecast, by Vaccine (2016-2027)

9.1.2.     Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.1.3.     U.S.

9.1.3.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.1.3.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.1.4.     Rest of North America

9.1.4.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.1.4.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.2.  Europe

9.2.1.     Market Revenue and Forecast, by Vaccine (2016-2027)

9.2.2.     Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.2.3.     UK

9.2.3.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.2.3.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.2.4.     Germany

9.2.4.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.2.4.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.2.5.     France

9.2.5.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.2.5.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.2.6.     Rest of Europe

9.2.6.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.2.6.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.3.  APAC

9.3.1.     Market Revenue and Forecast, by Vaccine (2016-2027)

9.3.2.     Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.3.3.     India

9.3.3.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.3.3.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.3.4.     China

9.3.4.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.3.4.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.3.5.     Japan

9.3.5.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.3.5.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.3.6.     Rest of APAC

9.3.6.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.3.6.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.4.  MEA

9.4.1.     Market Revenue and Forecast, by Vaccine (2016-2027)

9.4.2.     Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.4.3.     GCC

9.4.3.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.4.3.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.4.4.     North Africa

9.4.4.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.4.4.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.4.5.     South Africa

9.4.5.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.4.5.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.4.6.     Rest of MEA

9.4.6.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.4.6.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.5.  Latin America

9.5.1.     Market Revenue and Forecast, by Vaccine (2016-2027)

9.5.2.     Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.5.3.     Brazil

9.5.3.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.5.3.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

9.5.4.     Rest of LATAM

9.5.4.1.          Market Revenue and Forecast, by Vaccine (2016-2027)

9.5.4.2.          Market Revenue and Forecast, Therapeutic drugs (2016-2027)

Chapter 10.   Company Profiles

10.1.                 Pfizer Inc.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.                 Johnson & Johnson Services, Inc

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.                 Johnson & Johnson Services, Inc

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.                 Sanofi

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.                 Serum Institute of India

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.                 Serum Institute of India

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.                 Sanofi

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.                 F. Hoffmann-La Roche Ltd

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.                 Merck KGaA

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.              Janssen Pharmaceuticals, Inc.

10.10.1.                   Company Overview

10.10.2.                   Product Offerings

10.10.3.                   Financial Performance

10.10.4.                   Recent Initiatives

Chapter 11.   Research Methodology

11.1.                 Primary Research

11.2.                 Secondary Research

11.3.                 Assumptions

Chapter 12.   Appendix

12.1.                 About Us

12.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers